CONSERVE Plus Post-Approval Study (PAS)
Conserve Plus Total Hip Resurfacing System: A Non-Randomized, Multi-center, NewEnrollement Post Approval Study
Sponsor: MicroPort Orthopedics Inc.
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from MicroPort Orthopedics Inc.
- Joint Disease · Nov 2023
- Joint Disease · Dec 2021
- Joint Disease · Dec 2021
- Total Hip Replacement System · Phase PHASE4 · Oct 2013
More terminations from MicroPort Orthopedics Inc.
A observational or N/A phase clinical study on Other and Unspecified Injury to Hip and Thigh, this trial is terminated or withdrawn. The trial is conducted by MicroPort Orthopedics Inc. and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MicroPort Orthopedics Inc.
For direct contact, visit the study record on ClinicalTrials.gov .